EP Patent

EP2683375A1 — Colonoscopy - preparation

Assigned to Norgine BV · Expires 2014-01-15 · 12y expired

What this patent protects

The invention provides a colon cleansing solution comprising: a) 300 to 2000 mmol per litre ascorbate anion provided by ascorbic acid, one or more salts of ascorbic acid,or a mixture thereof; and b) 10 to 200 g per litre polyethylene glycol. The invention also provides methods an…

USPTO Abstract

The invention provides a colon cleansing solution comprising: a) 300 to 2000 mmol per litre ascorbate anion provided by ascorbic acid, one or more salts of ascorbic acid,or a mixture thereof; and b) 10 to 200 g per litre polyethylene glycol. The invention also provides methods and kits associated with, or making use of the solutions. The invention also provides a method of cleansing the colon of a subject comprising: -administering to the subject an effective amount of a first cleansing solution;and then after a time interval -administering to the subject an effective amount of a second cleansing solution, where in the two cleansing solutions are as described in the specification.

Drugs covered by this patent

Patent Metadata

Patent number
EP2683375A1
Jurisdiction
EP
Classification
Expires
2014-01-15
Drug substance claim
No
Drug product claim
No
Assignee
Norgine BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.